AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2297
0.00 (0.00%)
Pre-Market: 09:09
AIM ImmunoTech Total Liabilities (Quarterly) : 4.987M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.987M |
| March 31, 2026 | 6.46M |
| December 31, 2025 | 15.56M |
| September 30, 2025 | 11.57M |
| June 30, 2025 | 10.68M |
| March 31, 2025 | 10.10M |
| December 31, 2024 | 52.81M |
| September 30, 2024 | 10.68M |
| June 30, 2024 | 9.613M |
| March 31, 2024 | 11.36M |
| December 31, 2023 | 9.184M |
| September 30, 2023 | 5.259M |
| June 30, 2023 | 3.482M |
| March 31, 2023 | 2.473M |
| December 31, 2022 | 31.45M |
| September 30, 2022 | 3.59M |
| June 30, 2022 | 2.104M |
| March 31, 2022 | 0.854M |
| December 31, 2021 | 24.53M |
| September 30, 2021 | 1.033M |
| June 30, 2021 | 1.19M |
| March 31, 2021 | 3.122M |
| December 31, 2020 | 49.73M |
| September 30, 2020 | 3.052M |
| June 30, 2020 | 3.131M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.296M |
| December 31, 2019 | 51.87M |
| September 30, 2019 | 8.646M |
| June 30, 2019 | 7.26M |
| March 31, 2019 | 12.04M |
| December 31, 2018 | 47.90M |
| September 30, 2018 | 7.331M |
| June 30, 2018 | 4.494M |
| March 31, 2018 | 5.089M |
| December 31, 2017 | 4.542M |
| September 30, 2017 | 3.666M |
| June 30, 2017 | 3.26M |
| March 31, 2017 | 2.636M |
| December 31, 2016 | 3.375M |
| September 30, 2016 | 2.431M |
| June 30, 2016 | 4.429M |
| March 31, 2016 | 3.092M |
| December 31, 2015 | 2.433M |
| September 30, 2015 | 3.327M |
| June 30, 2015 | 3.102M |
| March 31, 2015 | 3.821M |
| December 31, 2014 | 4.436M |
| September 30, 2014 | 4.273M |
| June 30, 2014 | 4.181M |
| March 31, 2014 | 3.017M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.73M |
| Shareholders Equity (Quarterly) | 7.744M |
| Debt to Equity Ratio | 0.5063 |
| Current Ratio | 2.109 |
| Net Debt Paydown Yield | -3.40% |